It is a pharma public limited company based in Aurangabad, Maharashtra, India, established in 2004.
2004 | Aurangabad, Maharashtra, India | ActiveShri Swami Samarth Pharmaceuticals Limited, a active public limited company, was established on 08 October 2004 in Aurangabad, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230MH2004PLC149048. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 17 professional, Its leadership includes Tejaswini Shahadev Patil (Director), Vaishali Patil Shahadev (Director), Shahadev Ganpatrao Patil (Director). Past directors included Shrikant Nanabhau Khangar, Shashikala Vishwanath Patil, Ramesh Narayan Choudhari. It holds ₹1.67 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-24, Chikalthana,, Aurangabad, Maharashtra, 431006.
U24230MH2004PLC149048
149048
08 October 2004
₹1.50 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Shri Swami Samarth Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tejaswini Shahadev Patil | Director | 05 Apr 2022 | Current |
| Vaishali Patil Shahadev | Director | 05 Apr 2022 | Current |
| Shahadev Ganpatrao Patil | Director | 05 Apr 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 01 Nov 2013 | Past |
| Pramod Abcsdd | Director | 01 Oct 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 01 Oct 2013 | Past |
| Pramod Abcsdd | Director | 01 Jan 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shri Swami Samarth Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.48% increase. The company also saw a substantial fall in profitability, with a 68.79% decrease in profit. The company's net worth moved up by a moderate rise of 9.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Shri Swami Samarth Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,671,426.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2023 | Hdfc Bank Limited | ₹0.77 M | Open |
| 21 Mar 2005 | State Bank Of Hyerabad | ₹0.90 M | Open |
Explore comprehensive loan charge details -
Shri Swami Samarth Pharmaceuticals has a workforce of 17 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shri Swami Samarth Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Swami Samarth Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shri Swami Samarth Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Shri Swami Samarth Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.77 M with Charge ID 100812823 was registered on 31 Jul 2023. was documented.
The activity Tejaswini Shahadev Patil was appointed as a Director was appointed as a Director on 05 Apr 2022 & has been associated with this company since 3 years 8 months . was completed.
The activity Vaishali Patil Shahadev was appointed as a Director was appointed as a Director on 05 Apr 2022 & has been associated with this company since 3 years 8 months . was completed.
Shahadev Ganpatrao Patil was appointed as a Director was appointed as a Director on 05 Apr 2022 & has been associated with this company since 3 years 8 months . was recorded as a recent event.
The CIN of Shri Swami Samarth Pharmaceuticals Limited is U24230MH2004PLC149048.
Shri Swami Samarth Pharmaceuticals Limited is headquartered at C-24, Chikalthana,, Aurangabad, Maharashtra, 431006.
Shri Swami Samarth Pharmaceuticals Limited was incorporated on 08 October 2004.
The current directors of Shri Swami Samarth Pharmaceuticals Limited are
The primary industry of Shri Swami Samarth Pharmaceuticals Limited is Trade.
Shri Swami Samarth Pharmaceuticals Limited is unlisted.
The authorized capital of Shri Swami Samarth Pharmaceuticals Limited is ₹1.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Shri Swami Samarth Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX